Clinical Trial Update: Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating arsenic trioxide in combination with ascorbic acid for adult acute myeloid leukemia; the study was terminated and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• Ascorbic acid (Vitamin C)

Snippet

Sponsor: University of Southern California | Conditions: Acute Myelogenous Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2014-07-17